DEADLINE: 30 June 2021
The Gilead Asia Pacific Rainbow Grant supports community projects that aim to improve the lives of those affected by HIV. GAPRG believes that by working together, we are creating a world free of HIV.
All grant proposals are to be submitted online through the Gilead Grant portal tagging Gilead Asia Pacific Rainbow Grant Program, and specifying which focus area the proposal falls under. The Grants Committee will review and award grants based on how closely the proposed project aligns with the company’s mission and grant focus areas. Notifications of funding decisions will be done through the Gilead Grant portal. Focus Areas Under the overarching theme of “Building Back Better to End HIV”, there are three types of projects that we hope to support:
Focus 1: Education and Literacy
We cannot tackle the HIV #pandemic without renewed efforts to educate people on how to prevent infection and by eliminating the culture of silence surrounding the disease. In many countries in #Asia, public awareness campaigns to influence behavior change have been severely disrupted by #COVID19.
Focus 2: Reducing Health Disparities
The impact of the pandemic has pointed up longstanding health inequities and disproportionately affected people who are vulnerable to or living with HIV (PLWH). Improving livelihood opportunities and tackling the stigma around employing these people are critical to prevention efforts and better health outcomes.
Focus 3: Research for Impact
More than ever, we recognize the importance of reliable information for policy and programmatic planning. Up-to-date and accurate data are critical to empowering practitioners, policymakers and donors with the knowledge to design and fund interventions that will materially improve outcomes for PLWH.
Grantees must be in at least one of the following territories: Bangladesh, Bhutan, Brunei, Cambodia, China, Hong Kong, India, Indonesia, Japan, Laos, Malaysia, Maldives, Myanmar, Nepal, Pakistan, Papua New Guinea, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, and Vietnam.
Guidelines and full eligibility criteria on their website:
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.